Compare Pinterest Inc (PINS) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pinterest Inc vs ResMed Inc. — how do they compare? Pinterest Inc trades at $21.4 (market cap $11.63B), while ResMed Inc. trades at $230.05 (market cap $31.89B). The key difference: ResMed Inc. is far larger — about 2.7× Pinterest Inc's market cap, and ResMed Inc. pays a 1.16% dividend while Pinterest Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Pinterest Inc for 85 Days and ResMed Inc. for 51 Days on average.
| PINS | RMD | |
|---|---|---|
Market Cap | $11.63B | $31.89B |
Volume | 12,792,940 | 618,314 |
Sector | Media | Health |
52-Week High | $35.24 | $277.88 |
52-Week Low | $15.42 | $182.82 |
Typical Hold Time | 85 Days | 51 Days |
Enterprise Value | $11.55B | $31.24B |
Dividend Yield | — | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pinterest (PINS) trades at $20.525, up 1.06% with a bullish technical signal despite mixed oscillators. The company demonstrates strong revenue growth from $2.8B in 2022 to $4.2B in 2025, with consistent earnings beats in recent quarters. Analyst consensus is strongly positive with 54% buy ratings and a $27.93 price target, representing 36% upside potential from current levels.
PINS offers compelling growth potential driven by international monetization and visual search advertising innovations, though elevated valuation metrics (P/E 60.38) and insider selling activity warrant caution. The stock's primary catalysts include continued user growth and advertising revenue expansion, while risks center on competitive pressure and execution challenges in global markets.
ResMed (RMD) trades at $226.73, up 0.33% on the day, with a bullish technical signal supported by moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15 billion in 2025, with a net income margin of 26.94%, while cash flow from operations reached $1.75 billion. Recent news highlights an upcoming earnings report and positive analyst commentary on growth prospects.
The outlook is positive, driven by consistent earnings outperformance and a consensus price target of $242.70, implying upside. Key risks include competitive pressures and ongoing legal investigations. Institutional interest remains strong, with recent stake increases by funds. The stock's valuation metrics, such as a P/E of 21.74, appear reasonable given growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
